As of 2025-04-18, the Relative Valuation of XBiotech Inc (XBIT) is (12.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.94 USD, the upside of XBiotech Inc based on Relative Valuation is -527.6%.
The range of the Relative Valuation is (10.91) - (14.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.3x - 14.0x | 10.6x |
| Forward P/E multiples | 9.5x - 13.0x | 11.2x |
| Fair Price | (10.91) - (14.92) | (12.57) |
| Upside | -471.0% - -607.6% | -527.6% |
| Date | P/E |
| 2025-04-07 | -2.69 |
| 2025-04-04 | -2.50 |
| 2025-04-03 | -2.57 |
| 2025-04-02 | -2.74 |
| 2025-04-01 | -2.63 |
| 2025-03-31 | -2.82 |
| 2025-03-28 | -2.70 |
| 2025-03-27 | -2.82 |
| 2025-03-26 | -2.78 |
| 2025-03-25 | -2.87 |
| 2025-03-24 | -3.01 |
| 2025-03-21 | -3.00 |
| 2025-03-20 | -3.01 |
| 2025-03-19 | -3.03 |
| 2025-03-18 | -2.98 |
| 2025-03-17 | -3.07 |
| 2025-03-14 | -2.88 |
| 2025-03-13 | -2.74 |
| 2025-03-12 | -2.87 |
| 2025-03-11 | -2.77 |
| 2025-03-10 | -2.79 |
| 2025-03-07 | -2.83 |
| 2025-03-06 | -2.78 |
| 2025-03-05 | -2.83 |
| 2025-03-04 | -2.75 |
| 2025-03-03 | -2.92 |
| 2025-02-28 | -3.07 |
| 2025-02-27 | -2.71 |
| 2025-02-26 | -2.61 |
| 2025-02-25 | -2.63 |
| 2025-02-24 | -2.67 |
| 2025-02-21 | -2.60 |
| 2025-02-20 | -2.72 |
| 2025-02-19 | -2.71 |
| 2025-02-18 | -2.64 |
| 2025-02-14 | -2.85 |
| 2025-02-13 | -2.80 |
| 2025-02-12 | -2.80 |
| 2025-02-11 | -2.87 |
| 2025-02-10 | -2.89 |
| 2025-02-07 | -2.70 |
| 2025-02-06 | -2.86 |
| 2025-02-05 | -2.98 |
| 2025-02-04 | -2.83 |
| 2025-02-03 | -2.90 |
| 2025-01-31 | -3.01 |
| 2025-01-30 | -3.15 |
| 2025-01-29 | -3.14 |
| 2025-01-28 | -3.03 |
| 2025-01-27 | -3.17 |